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Mental health of HIV-infected patients: A severe, but 
Overlooked Problem
Jun Yong Choi 
Department of Internal Medicine, AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea
HIV-infected patients are known to have severe psychosocial problems; however, clinicians tend to overlook these psychosocial 
issues. Song et al. identified depression and anxiety as the most common mental illnesses among HIV-infected patients. Psy-
chosocial issues are important factors and are associated with poor adherence, which leads to treatment failure and resistance. 
Clinicians who tend to HIV patients should be attentive to the patients’ psychosocial problems and regularly conduct screening 
for depressive disorders. Mental health must be addressed to improve the quality of life of patients with HIV/AIDS. 
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Editorial
The introduction of antiretroviral treatment (ART) into clini-
cal practice has led to dramatic reductions in morbidity and 
mortality associated with HIV infection [1]. With the success 
of ART, HIV infection is no longer an acutely devastating ill-
ness, but a controllable disease. However, many non-AIDS 
complications that limit the quality of life of HIV-infected per-
sons have emerged. Mental illnesses such as HIV-associated 
neurocognitive disorder (HAND) and depression are impor-
tant complications limiting the quality of life of HIV/AIDS pa-
tients. HIV enters the central nervous system (CNS) early after 
infection. Although HIV does not directly infect neurons, it is 
frequently associated with structural and functional brain ab-
normalities. Significant brain involvement occurs in individu-
als with an AIDS-defining opportunistic condition (approxi-
mately 50%), but neurocognitive changes also occur in about 
one-third of individuals in the early, medically asymptomatic 
phases of the disease. Depression is the most common mental 
illness among HIV-infected persons. There is a higher preva-
lence of depression in HIV infected persons (20–40% versus 
7% in general population) due to stigma, sexual dysfunction, 
side effects of ART, and co-morbidities [2].  
Song et al. [8] investigated the prevalence and risk factors for 
depression among HIV-infected Koreans. They found that the 
prevalence of depression was more than 20% in this popula-
tion. Co-morbidities and unemployment were risk factors for 
depression among HIV-infected Koreans. In addition, patients 
with depression tended to miss their clinical appointments. 
Few studies have examined the psychosocial aspects of HIV-
infected Koreans. However, Lee et al. did compare the psycho-
social variables among 27 HIV-infected Koreans, 29 patients 
who received hematopoietic stem cell transplantation, 30 
healthy controls [3]. In their study, patients were evaluated us-
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ing hospital anxiety and depression scales. Lee et al. found 
that compared with healthy controls, HIV-infected patients 
had higher scores of depression and anxiety as well as higher 
perceived stress. HIV patients also had a lower family support 
than both hematopoietic stem cell transplantation patients 
and healthy controls. 
In another study, Lee et al. evaluated the psychosocial fac-
tors associated with biological markers in 50 HIV-infected Ko-
reans [4]. They found a significant correlation between psy-
chosocial factors and CD4+ cell counts. In the Stress Response 
Inventory, subscales for tension, aggression, depression, and 
frustration showed that these factors had a negative correla-
tion with the CD4+ cell count. In addition, distancing and self-
control in the coping scale also had a negative correlation 
with CD4+ cell count. They concluded that the use of a passive 
coping strategy, like distancing, might be an important factor 
influencing the progression of HIV infection. Lee et al. indicat-
ed that psychosocial interventions are needed for HIV-infect-
ed patients. 
Studies have consistently shown that many HIV-infected Ko-
reans have severe psychosocial problems such as depression 
and anxiety. These findings are consistent with those from 
studies in other countries. A meta-analysis showed that the fre-
quency of major depressive disorder was almost 2 times higher 
in HIV-positive subjects than in HIV-negative subjects [2].  
Although adherence to ART is associated with HIV viral sup-
pression, reduced rates of resistance, increased survival, and 
improved quality of life, poor adherence is very common in 
HIV-infected patients receiving lifelong ART [5]. Psychosocial 
issues such as depression, homelessness, low social support, 
stressful life events, or psychosis are factors associated with 
non-adherence [6]. Song et al. [8] found that depressed Kore-
an patients were more likely to miss clinical appointments. In 
addition, they found that only small proportion of Korean pa-
tients with depressive disorder are referred to neuropsycholo-
gists. Therefore, prior to initiating ART, clinicians should 
conduct a psychiatric assessment of the patient and consider 
ways to improve his/her mental health. 
The European AIDS Clinical Society (EACS) guidelines rec-
ommend that clinicians perform screening for depression ev-
ery 1–2 years. Depression screening is assessed using 2 main 
questions: (1) “Have you often felt depressed, sad or without 
hope in the last few months?” and (2) “Have you lost interest 
in activities that you usually enjoy?” [7]. If the patient has a de-
pressive disorder, a prescription for antidepressants such as 
selective serotonin-reuptake inhibitors (SSRIs), dual-action 
reuptake inhibitors, or mixed action newer agents should be 
given while considering the accompanying drug interactions 
between antidepressants and antiretroviral drugs. Patients 
with severe depression should be referred to a Psychiatry spe-
cialist. 
People with HIV/AIDS in Korea face tremendous psychoso-
cial challenges, including HIV-related stigma, lack of social 
support, and mental health issues. These issues pose a serious 
threat to their human right to health and quality of life. Soci-
ety, clinicians, family, as well as the patients themselves 
should make every effort necessary to help patients overcome 
these challenges. 
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